Omega Stock Financials

OMGA
 Stock
  

USD 5.42  0.29  5.65%   

Please use analysis of Omega Therapeutics fundamentals to determine if markets are correctly pricing the firm. We were able to analyze and collect data for twenty-six available financial ratios for Omega Therapeutics, which can be compared to its competitors. To ensure the equity is not overpriced, please check all Omega Therapeutics financials, including its number of shares shorted, net income, book value per share, as well as the relationship between the revenue and total debt . Given that Omega Therapeutics has a number of shares shorted of 538.79 K, we recommend you to check out Omega Therapeutics recent market performance to make sure the company can sustain itself down the road. Use Omega Therapeutics to enhance the returns of your portfolios. Benchmarks are essential to demonstrate the utility of optimization algorithms. The stock experiences a very speculative upward sentiment. Check odds of Omega Therapeutics to be traded at $6.78 in 90 days.
  
With this module, you can analyze Omega financials for your investing period. You should be able to track the changes in Omega Therapeutics individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Understanding current and past Omega Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Omega Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Omega Therapeutics' assets may result in an increase in income on the income statement.
Chance Of Financial Distress
Less than 31
Omega Therapeutics has less than 31 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Omega Therapeutics stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Omega Therapeutics' official financial statements usually reflect Omega Therapeutics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Omega Therapeutics. For example, before you start analyzing numbers published by Omega accountants, it's critical to develop an understanding of what Omega Therapeutics' liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Omega Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Omega Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Omega Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Omega Therapeutics. Please utilize our Beneish M Score to check the likelihood of Omega Therapeutics' management to manipulate its earnings.

Omega Therapeutics Company Summary

Omega Therapeutics competes with Xenia Hotels, Hong Kong, Hilton, Sotherly Hotels, and Intercontinental. Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. The company was incorporated in 2016 and is headquartered in Cambridge, Massachusetts. Omega Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 79 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
Business Address20 Acorn Park
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.omegatherapeutics.com
Phone617 949 4360
CurrencyUSD - US Dollar
You should never invest in Omega Therapeutics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Omega Stock, because this is throwing your money away. Analyzing the key information contained in Omega Therapeutics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Omega Therapeutics Key Financial Ratios

Generally speaking, Omega Therapeutics' financial ratios allow both analysts and investors to convert raw data from Omega Therapeutics' financial statements into concise, actionable information that can be used to evaluate the performance of Omega Therapeutics over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Omega Therapeutics reports annually and quarterly.

Omega Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Omega Therapeutics's current stock value. Our valuation model uses many indicators to compare Omega Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Omega Therapeutics competition to find correlations between indicators driving Omega Therapeutics's intrinsic value. More Info.
Omega Therapeutics is considered to be number one stock in return on equity category among related companies. It is considered to be number one stock in current ratio category among related companies . . Comparative valuation analysis is a catch-all model that can be used if you cannot value Omega Therapeutics by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Omega Therapeutics' Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Omega Therapeutics' earnings, one of the primary drivers of an investment's value.

Omega Therapeutics Systematic Risk

Omega Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Omega Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on Omega Therapeutics correlated with the market. If Beta is less than 0 Omega Therapeutics generally moves in the opposite direction as compared to the market. If Omega Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Omega Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Omega Therapeutics is generally in the same direction as the market. If Beta > 1 Omega Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
.

About Omega Therapeutics Financials

What exactly are Omega Therapeutics Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Omega Therapeutics' income statement, its balance sheet, and the statement of cash flows. Potential Omega Therapeutics investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Omega Therapeutics investors may use each financial statement separately, they are all related. The changes in Omega Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Omega Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Omega Therapeutics is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Omega has grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Omega Therapeutics October 3, 2022 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Omega Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Omega Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Omega Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Omega Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Omega Therapeutics's daily price indicators and compare them against related drivers.
Downside Deviation5.97
Information Ratio0.1043
Maximum Drawdown34.15
Value At Risk(8.66)
Potential Upside9.97
Please check Your Equity Center. Note that the Omega Therapeutics information on this page should be used as a complementary analysis to other Omega Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Complementary Tools for Omega Stock analysis

When running Omega Therapeutics price analysis, check to measure Omega Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Omega Therapeutics is operating at the current time. Most of Omega Therapeutics' value examination focuses on studying past and present price action to predict the probability of Omega Therapeutics' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Omega Therapeutics' price. Additionally, you may evaluate how the addition of Omega Therapeutics to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Go
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Go
Commodity Channel Index
Use Commodity Channel Index to analyze current equity momentum
Go
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Go
Is Omega Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Omega Therapeutics. If investors know Omega will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Omega Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Omega Therapeutics is measured differently than its book value, which is the value of Omega that is recorded on the company's balance sheet. Investors also form their own opinion of Omega Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Omega Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Omega Therapeutics' market value can be influenced by many factors that don't directly affect Omega Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Omega Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine Omega Therapeutics value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Omega Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.